查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468502

中性粒细胞减少症治疗市场报告（按治疗方法（集落刺激因子、抗生素、抗真菌药物、抗病毒药物）、配销通路（医院药房、零售药房、线上药房）和地区）2024-2032 年

Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球IMARC Group中性白血球减少症治疗市场规模达153亿美元。云端平台的日益普及、智慧型手机销售的不断上升以及广泛的研发 (R&D) 活动是推动市场发展的一些关键因素。

中性粒细胞减少症是一种以帮助身体抵抗感染的白血球 (WBC) 计数异常低为特征的疾病。它是由各种情况或疾病引起的，包括感染、化疗、先天性骨髓异常、自体免疫疾病和某些药物（药物引起的中性粒细胞减少症）。嗜中性球是在骨髓中产生的，骨髓是较大骨骼（如椎骨、肋骨和骨盆）中的海绵组织。中性粒细胞减少症的治疗包括抗生素、抗真菌和抗病毒药物，透过消灭攻击身体的有害真菌、酵母和细菌来帮助对抗感染。这些药物有助于降低感染的可能性并刺激骨髓产生更多的白血球。

中性白血球减少症治疗市场趋势：

对中性粒细胞减少症和化疗相关副作用的认识不断提高是推动市场成长的关键因素之一。与此一致，对胶囊和片剂形式且给药途径方便的口服药物的需求不断增长，有利于市场成长。此外，主要参与者积极传播有关中性粒细胞减少症的预防措施、早期诊断和有效治疗的相关资讯和知识，这反过来又推动了市场的成长。此外，群众对可用治疗替代方案的认识不断增强，这是另一个促进成长的因素。除此之外，製造商还专注于推出具有成本效益的中性粒细胞减少症治疗药物，这正在促进市场成长。此外，利用新型药物传递方法有助于提高患者的便利性，进而提高患者的依从性，对市场成长产生正面影响。除此之外，发烧性中性粒细胞减少症药物的增加以及促进和生产生物仿製药的新立法的实施正在为市场创造积极的前景。该市场的另一个推动力是透过线上零售入口网站（例如註册网站）轻鬆获得药物，这提供了以实惠的价格订购和购买药物的便利性。其他因素，包括广泛的研发（R&D）活动、创新和有效药物的推出、癌症发病率上升、由于基础设施改善而更容易获得医疗保健设施、消费者支出能力不断增强以及政府实施各种促进癌症发展的倡议公共卫生，预计将推动市场成长。

本报告回答的关键问题

  • 全球中性白血球减少症治疗市场有多大？
  • 2024-2032年全球嗜中性白血球减少症治疗市场的预期成长率为何？
  • 推动全球中性白血球减少症治疗市场的关键因素是什么？
  • COVID-19 对全球嗜中性白血球减少症治疗市场有何影响？
  • 根据治疗方法，全球中性白血球减少症治疗市场的细分情况如何？
  • 基于配销通路的全球中性粒细胞减少症治疗市场的细分情况如何？
  • 全球中性粒细胞减少症治疗市场的关键区域有哪些？
  • 全球中性粒细胞减少症治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球中性白血球减少症治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依处理方式

  • 集落刺激因子
    • 市场走向
    • 市场预测
  • 抗生素
    • 市场走向
    • 市场预测
  • 抗霉菌药
    • 市场走向
    • 市场预测
  • 抗病毒药
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Amgen Inc.
    • BeyondSpring Inc.
    • Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
    • Pfizer Inc.
    • Sandoz Inc. (Novartis AG)
    • Spectrum Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112024A6852

The global neutropenia treatment market size reached US$ 15.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. The increasing adoption of cloud platforms, escalating sales of smartphones and extensive research and development (R&D) activities represent some of the key factors driving the market.

Neutropenia is a disease characterized by an abnormally low count of white blood cells (WBCs) that help the body fight infections. It is caused by various situations or diseases, including infections, chemotherapy, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia). Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones, such as the vertebrae, ribs, and pelvis. Neutropenia treatment includes antibiotics, antifungals, and antiviral medications that help fight against infection by destroying harmful fungi, yeast, and bacteria that attack the body. These medications assist in reducing the likelihood of infections and stimulate the bone marrow to produce more white blood cells.

Neutropenia Treatment Market Trends:

The rising awareness of neutropenia and chemotherapy-related side effects is one of the key factors driving the market growth. In line with this, the increasing demand for oral drugs that are available in capsule and tablet form and consist of convenient routes of administration is favoring the market growth. Moreover, key players are actively engaged in disseminating relevant information and knowledge regarding preventive measures, early diagnosis, and effective treatment of neutropenia, which, in turn, is propelling the market growth. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is acting as another growth-inducing factor. In addition to this, manufacturers are focusing on the introduction of cost-effective medicines for neutropenia treatment, which is facilitating the market growth. Additionally, the utilization of novel drug delivery methods that helps in improving patient convenience, which leads to improved patient adherence, is positively influencing the market growth. Besides this, the increase in febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars are creating a positive outlook for the market. The market is also driven by the easy availability of medications through online retail portals, such as registered websites, which provides convenience of ordering and procurement of medications at affordable price-points. Other factors, including extensive research and development (R&D) activities, the introduction of innovative and effective drugs, rising incidences of cancer, easy access to healthcare facilities owing to improved infrastructure, increasing expenditure capacities of consumers and the implementation of various government initiatives for promoting public health, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global neutropenia treatment market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on treatment and distribution channel.

Treatment Insights:

Colony-Stimulating Factors

Antibiotics

Antifungals

Antivirals

The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the treatment. This includes colony-stimulating factors, antibiotics, antifungals and antivirals. According to the report, colony-stimulating factors represented the largest segment.

Distribution channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has provided a detailed breakup and analysis of the neutropenia treatment market based on the distribution channel. This includes hospital, retail, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for neutropenia treatment. Some of the factors driving the North America neutropenia treatment market included increasing demand for internet-enabled services by enterprises, extensive research and development (R&D) activities, and various technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global neutropenia treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amgen Inc., BeyondSpring Inc., Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited), Pfizer Inc., Sandoz Inc. (Novartis AG), Spectrum Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global neutropenia treatment market?
  • 2. What is the expected growth rate of the global neutropenia treatment market during 2024-2032?
  • 3. What are the key factors driving the global neutropenia treatment market?
  • 4. What has been the impact of COVID-19 on the global neutropenia treatment market?
  • 5. What is the breakup of the global neutropenia treatment market based on the treatment?
  • 6. What is the breakup of the global neutropenia treatment market based on the distribution channel?
  • 7. What are the key regions in the global neutropenia treatment market?
  • 8. Who are the key players/companies in the global neutropenia treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neutropenia Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Treatment

  • 6.1 Colony-Stimulating Factors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antibiotics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antifungals
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Antivirals
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amgen Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BeyondSpring Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
    • 13.3.3 Kyowa Hakko Kirin Co. Ltd. (Kirin Holdings Company Limited)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Pfizer Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Sandoz Inc. (Novartis AG)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Spectrum Pharmaceuticals Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Teva Pharmaceutical Industries Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Viatris Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Neutropenia Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Neutropenia Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Neutropenia Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Neutropenia Treatment Market: Breakup by Treatment (in %), 2023
  • Figure 5: Global: Neutropenia Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 6: Global: Neutropenia Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Neutropenia Treatment (Colony-Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Neutropenia Treatment (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Neutropenia Treatment (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Neutropenia Treatment (Antifungals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Neutropenia Treatment (Antifungals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Neutropenia Treatment (Antivirals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Neutropenia Treatment (Antivirals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Neutropenia Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Neutropenia Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Neutropenia Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Neutropenia Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Neutropenia Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Neutropenia Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia-Pacific: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia-Pacific: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Neutropenia Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Neutropenia Treatment Market: Breakup by Country (in %), 2023
  • Figure 69: Middle East and Africa: Neutropenia Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Global: Neutropenia Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Neutropenia Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Neutropenia Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neutropenia Treatment Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Neutropenia Treatment Market Forecast: Breakup by Treatment (in Million US$), 2024-2032
  • Table 3: Global: Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Neutropenia Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Neutropenia Treatment Market: Competitive Structure
  • Table 6: Global: Neutropenia Treatment Market: Key Players